0
Skip to Content
Purilogics
Purilogics
About
Our mission
Our Team
Careers
Ethics & Compliance
Products
Products overview
Purexa™ PrA
Purexa™ MCP
Purexa™ NAEX
Purexa™ OdT
Technology
How it works
Case Studies
Patents
News
Contact Us
Purilogics
Purilogics
About
Our mission
Our Team
Careers
Ethics & Compliance
Products
Products overview
Purexa™ PrA
Purexa™ MCP
Purexa™ NAEX
Purexa™ OdT
Technology
How it works
Case Studies
Patents
News
Contact Us
Folder: About
Back
Our mission
Our Team
Careers
Ethics & Compliance
Folder: Products
Back
Products overview
Purexa™ PrA
Purexa™ MCP
Purexa™ NAEX
Purexa™ OdT
Folder: Technology
Back
How it works
Case Studies
Patents
News
Contact Us
Purilogics Awarded Grant from NIH to Develop Affinity Chromatography Membranes for Improved Vaccine Purification
jeremy hogenbaum 5/7/20 jeremy hogenbaum 5/7/20

Purilogics Awarded Grant from NIH to Develop Affinity Chromatography Membranes for Improved Vaccine Purification

As part of the Small Business Innovative Research (SBIR) program, the National Institute of Allergy and Infectious Diseases (NIAID) has awarded Purilogics with a grant to commercialize affinity membrane adsorbers for purification of influenza vaccines.

Read More

Contact us ⭷

215 Innovation Dr, Suite D
Greenville, SC 29607


Purilogics.Information@donaldson.com

 
 

Sitemap

Home
Technology
Contact
News
About
Our Team
Ethics & Compliance
Products

 

Products

Purexa™ Products overview
Purexa™ PrA (PDF)
Purexa™ OdT (PDF)
Purexa™ MCP (PDF)
Purexa™ NAEX Plus (PDF)

 

© 2025 by Purilogics. Our Privacy Policy, Terms and Conditions of Use,  Terms & Conditions of Sale